Sickle cell disease is an inherited blood disorder that affects about one in 12 African Americans. During National Minority Health Month, learn more about NCATS’ work on a potential treatment.
NCATS researchers develop new technologies that can be transferred — through collaborations and licenses — to others for further research, development and commercialization.
Collaborators from NCATS and NCI published a study demonstrating the system’s power to find drug combinations to treat a type of blood cancer.
Get the Center’s latest news, announcements and funding opportunities delivered directly to your inbox.
How is NCATS advancing translational research? Learn more about the Center's work and some of its early successes.
MORE CENTER NEWS
Regulatory agencies face record applications for rare disease therapies.
Connecting researchers and industry to find new treatments for patients.
- Active Skepticism: Beyond the IOM’s CTSA Report • Science Translational Medicine
- Wisconsin Research Shows Green Space Keeps You from Feeling Blue • University of Wisconsin School of Medicine and Public Health
- IU Bloomington Faculty Awarded Indiana Clinical and Translational Sciences Grants • Indiana University
- More News & Events...